Stay updated on Nivolumab with 5-azacytidine in Childhood AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T03:27:53.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    No Change Detected
  5. Check
    28 days ago
    Change Detected
    Summary
    Locations were consolidated into a single 'Locations' section, replacing the previous separate state entries (California, Georgia, Maryland, New York, North Carolina, Ohio, Tennessee, Texas, Utah, Washington). The HHS Vulnerability Disclosure link was removed and the revision label updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T20:42:57.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; no study details or content appear to be changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:29:00.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Removed the government funding status notice from the page; the banner only conveyed operational status and its removal does not affect the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:49:35.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    No substantive changes to the study page content were detected; only minor formatting or layout differences appear in the screenshots.
    Difference
    0.4%
    Check dated 2025-11-03T20:40:41.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.
    Difference
    3%
    Check dated 2025-10-06T04:50:15.000Z thumbnail image

Stay in the know with updates to Nivolumab with 5-azacytidine in Childhood AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.